Refine Search
(258)
(519)
(871)
(1781)

NEW Immuno-oncology Development Trends and Opportunities

  • $7,995
  • November 2018
Add to Basket Quick View Add to Saved List

Immuno-oncology (IO) is the treatment of cancer with therapies that stimulate or suppress the body’s own immune system. Several distinct modalities of IO therapy exist, including bispecific T-cell engaging monoclonal antibodies, cellular immuno...

NEW Brexit and the Healthcare Industry – Implications for Pharma, Q3 2018

  • $500
  • November 2018
Add to Basket Quick View Add to Saved List

It has been over two years since the UK voted to leave the EU. As Brexit deadlines loom, negotiations are still ongoing to determine the UK’s relationship with the EU after Brexit.

This report provides an assessment of how the pharmaceuti...

NEW Seasonal Influenza: Competitive Landscape to 2026

  • $3,495
  • November 2018
Add to Basket Quick View Add to Saved List

Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses designated as influenza types A, B, and C. The influenza A H1N1 and H3N2, and influenza B strains are those responsible for season...

Alzheimer’s Disease: Dynamic Market Forecast to 2026

  • $8,495
  • October 2018
Add to Basket Quick View Add to Saved List

Alzheimer’s Disease (AD) is a rapidly evolving field in which new developments are constantly influencing the market landscape.

The Dynamic Market Forecast is designed to help clients stay abreast of the latest news in the AD space, incl...

Digital Landscape: Asthma

  • $6,000
  • October 2018
Add to Basket Quick View Add to Saved List

The Digital Landscape Asthma report analyzes digital activities undertaken by pharma in support of therapies for asthma

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – US

  • $1,995
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – US”. The report is an essential source of information and analysis on the healthcare, regulatory a...

Digital Landscape: HIV

  • $6,000
  • October 2018
Add to Basket Quick View Add to Saved List

The Digital Landscape HIV report analyzes digital activities undertaken by pharma in support of therapies for the treatment of HIV

Glioblastoma Multiforme (GBM): Opportunity Analysis and Forecasts to 2027

  • $10,995
  • October 2018
Add to Basket Quick View Add to Saved List

Glioblastoma multiforme (GBM), otherwise known as Grade IV astrocytoma, is the most aggressive form of brain cancer and characterized as a disease with one of the highest unmet needs in oncology, with patients having a median overall survival (...

Brain Cancer: Epidemiology Forecast to 2027

  • $3,995
  • October 2018
Add to Basket Quick View Add to Saved List

Primary brain cancer is defined as a malignant neoplasm that originates in the central nervous system (CNS), which consists of the brain and spinal cord, including the brain stem. The type and severity of a brain tumor is defined by the cells f...

Crohn’s Disease: Dynamic Market Forecast to 2026

  • $8,495
  • October 2018
Add to Basket Quick View Add to Saved List

Crohn’s disease is a form of inflammatory bowel disease, which is comprised of two chronic autoimmune diseases that cause intestinal inflammation: Crohn's disease and ulcerative colitis. In Crohn’s disease, chronic inflammation may affect a...

Obesity: Competitive Landscape to 2026

  • $3,495
  • October 2018
Add to Basket Quick View Add to Saved List

Obesity is a preventable chronic condition, defined as abnormal or excessive fat accumulation characterized by raised body mass index (BMI ≥30), which is a major risk factor for chronic diseases such as cardiovascular diseases (CVD), diabetes, ...

Robotics in Healthcare - Thematic Research

  • $1,950
  • October 2018
Add to Basket Quick View Add to Saved List

Increasingly, robots are seen as a solution to many of the structural problems facing the developed world—sagging productivity, aging populations, swelling healthcare budgets, and even epidemics of depression and an increasingly fragmented soci...

AIDS - Related Primary CNS Lymphoma Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “AIDS - Related Primary CNS Lymphoma Global Clinical Trials Review, H2, 2018" provides an overview of AIDS - Related Primary CNS Lymphoma clinical trials scenario. This report provides top line data ...

AIDS Associated Dementia Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “AIDS Associated Dementia Global Clinical Trials Review, H2, 2018" provides an overview of AIDS Associated Dementia clinical trials scenario. This report provides top line data relating to the clinic...

Alcohol Addiction Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Alcohol Addiction Global Clinical Trials Review, H2, 2018" provides an overview of Alcohol Addiction clinical trials scenario. This report provides top line data relating to the clinical trials on A...

Report Catalogue

Strategic Insight Reports

Market Analysis Reports

Databooks